Skip to content

DR. SALVAGGIO

Active
Private limited companyfounded 20233 yrs activeRue de la Drève(N) 47, 4121 Neupré, BelgiumKBO/BCE: BE 0803.242.350
Summary

DR. SALVAGGIO has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €94,808 and a net result of €26,570. Equity is growing by ~58.9% per year across the filed fiscal years. Its solvency ranks better than 59% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability94▼-6
Solvency97▲+22
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity ample (current ratio 3.26 against 1.85 in 2024; short-term debt: 28% and cash: 88.1% of total assets), and 28% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72%
Return on assets
20.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-07-2026, 26 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
26 d early
2024
28 d late
2023
11 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 3 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 21 July (3 of the last 3 filed years within 38 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

DR. SALVAGGIO was incorporated on 27 June 2023 as a Private limited company.1 Total assets rose from EUR 64,079 in 2023 to EUR 131,658 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€94,808▲ 38.9%
2024 · €68,238
Total assets
€131,658▼ 4.4%
2024 · €137,647
Net result
€26,570▼ 50.6%
2024 · €53,783
Working capital
€83,384▲ 42.4%
2024 · €58,549
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line202320242025
Operating result€16,423-€69,740▲ 325%€36,563▼ 47.6%
Net result€12,456below the sector's middle half-€53,783within the sector's middle half▲ 332%€26,570within the sector's middle half▼ 50.6%
Equity€14,456below the sector's middle half-€68,238within the sector's middle half▲ 372%€94,808within the sector's middle half▲ 38.9%
Total assets€64,079below the sector's middle half-€137,647within the sector's middle half▲ 115%€131,658within the sector's middle half▼ 4.4%
Debt€49,623-€69,408▲ 39.9%€36,849▼ 46.9%
Working capital-€13,911below the sector's middle half-€58,549within the sector's middle half€83,384within the sector's middle half▲ 42.4%
Solvency22.6%below the sector's middle half-49.6%within the sector's middle half▲ 27.0pp72.0%within the sector's middle half▲ 22.4pp
Current ratio0.72below the sector's middle half-1.85within the sector's middle half▲ 1.133.26within the sector's middle half▲ 1.41
Return on assets (ROA)19.4%within the sector's middle half-39.1%above the sector's middle half▲ 19.6pp20.2%within the sector's middle half▼ 18.9pp
Staff (FTE)0.5-0.9▲ 80.0%
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000Operating result 2023: €16,423€16,423Net result 2023: €12,456€12,456Operating result 2024: €69,740€69,740Net result 2024: €53,783€53,783Operating result 2025: €36,563€36,563Net result 2025: €26,570€26,570202320242025€0€20,000€40,000€60,000Operating result 2023: €16,423€16,400Net result 2023: €12,456€12,500Operating result 2024: €69,740€69,700Net result 2024: €53,783€53,800Operating result 2025: €36,563€36,600Net result 2025: €26,570€26,600202320242025
The operating result falls in 2025; 2025 is 48% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €131,658
Fixed assets €11,424 ▲ 10.3%
Current assets €120,234 ▼ 5.5%
Equity and liabilities €131,658
Equity €94,808 ▲ 38.9%
Debt €36,849 ▼ 46.9%
Debt's share of the balance-sheet total falls from 50.4% to 28.0%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€40,593▼
2024 · €72,465
Cash flow
€30,601▼
2024 · €56,508
Debt to equity
0.39▼
2024 · 1.02
ROE
28.0%▼
2024 · 78.8%
Interest coverage
35.36▼
2024 · 53.76
Debt ≤ 1 year
€36,849▼
2024 · €68,737
Income taxes
€9,218▼
2024 · €14,637
Staff costs
€27,920▼
2024 · €30,474
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€137,647€131,658▼
Formation expenses20€0-
Fixed assets21/28€10,361€11,424▲
Tangible fixed assets22/27€9,987€11,050▲
Plant, machinery and equipment23€4,034€4,584▲
Furniture and vehicles24€4,795€5,585▲
Other tangible fixed assets26€1,158€881▼
Financial fixed assets28€374€374=
Current assets29/58€127,286€120,234▼
Amounts receivable within one year40/41€1,202€1,548▲
Trade receivables40€1,202€1,009▼
Other amounts receivable41-€539
Cash at bank and in hand54/58€112,280€115,979▲
Deferred charges and accrued income490/1€13,804€2,707▼
Equity and liabilities
Total equity and liabilities10/49€137,647€131,658▼
Equity10/15€68,238€94,808▲
Contributions10/11€2,000€2,000=
Profit (loss) carried forward14€66,238€92,808▲
Amounts payable17/49€69,408€36,849▼
Amounts payable within one year42/48€68,737€36,849▼
Trade debts44€11,644€15,850▲
Suppliers440/4€11,644€15,850▲
Taxes, remuneration and social security45€28,830€20,999▼
Taxes450/3€19,931€14,209▼
Remuneration and social security454/9€8,899€6,790▼
Other amounts payable47/48€28,263€0▼
Accrued charges and deferred income492/3€671€0▼
Income statement Code20242025
Remuneration, social security and pensions62€30,474€27,920▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,725€4,031▲
Other operating charges640/8€1,082€402▼
Non-recurring operating charges66A€3,558€6,239▲
Gross operating margin9900€107,579€75,154▼
Operating profit (loss)9901€69,740€36,563▼
Financial income75/76B€28€373▲
Recurring financial income75€28€373▲
Financial charges65/66B€1,348€1,148▼
Recurring financial charges65€1,348€1,148▼
Profit (loss) for the period before taxes9903€68,420€35,788▼
Income taxes67/77€14,637€9,218▼
Profit (loss) for the period9904€53,783€26,570▼
Profit (loss) for the period to be appropriated9905€53,783€26,570▼
Appropriation of the result
Profit (loss) to be appropriated9906€66,238€92,808▲
Profit (loss) brought forward from the previous period14P€12,456€66,238▲

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Remuneration, social security and pensions62€13,306€30,474€27,920▼ 8.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,831€2,725€4,031▲ 47.9%
Other operating charges640/8€367€1,082€402▼ 62.9%
Non-recurring operating charges66A-€3,558€6,239▲ 75.4%
Gross operating margin9900€33,928€107,579€75,154▼ 30.1%
Operating profit (loss)9901€16,423€69,740€36,563▼ 47.6%
Financial income75/76B€0€28€373▲ 1,241%
Recurring financial income75€0€28€373▲ 1,241%
Financial charges65/66B€205€1,348€1,148▼ 14.8%
Recurring financial charges65€205€1,348€1,148▼ 14.8%
Profit (loss) for the period before taxes9903€16,218€68,420€35,788▼ 47.7%
Income taxes67/77€3,762€14,637€9,218▼ 37.0%
Profit (loss) for the period9904€12,456€53,783€26,570▼ 50.6%
Profit (loss) for the period to be appropriated9905€12,456€53,783€26,570▼ 50.6%
Line202320242025Change
Assets
Total assets20/58€64,079€137,647€131,658▼ 4.4%
Formation expenses20€1,049€0--
Fixed assets21/28€27,331€10,361€11,424▲ 10.3%
Tangible fixed assets22/27€26,958€9,987€11,050▲ 10.6%
Plant, machinery and equipment23€301€4,034€4,584▲ 13.6%
Furniture and vehicles24€26,656€4,795€5,585▲ 16.5%
Other tangible fixed assets26-€1,158€881▼ 23.9%
Financial fixed assets28€374€374€374=
Current assets29/58€35,698€127,286€120,234▼ 5.5%
Amounts receivable within one year40/41€650€1,202€1,548▲ 28.8%
Trade receivables40€650€1,202€1,009▼ 16.1%
Other amounts receivable41--€539-
Cash at bank and in hand54/58€30,220€112,280€115,979▲ 3.3%
Deferred charges and accrued income490/1€4,827€13,804€2,707▼ 80.4%
Equity and liabilities
Total equity and liabilities10/49€64,079€137,647€131,658▼ 4.4%
Equity10/15€14,456€68,238€94,808▲ 38.9%
Contributions10/11€2,000€2,000€2,000=
Profit (loss) carried forward14€12,456€66,238€92,808▲ 40.1%
Amounts payable17/49€49,623€69,408€36,849▼ 46.9%
Amounts payable within one year42/48€49,609€68,737€36,849▼ 46.4%
Trade debts44€2,862€11,644€15,850▲ 36.1%
Suppliers440/4€2,862€11,644€15,850▲ 36.1%
Taxes, remuneration and social security45€16,065€28,830€20,999▼ 27.2%
Taxes450/3€9,598€19,931€14,209▼ 28.7%
Remuneration and social security454/9€6,467€8,899€6,790▼ 23.7%
Other amounts payable47/48€30,683€28,263€0▼ 100%
Accrued charges and deferred income492/3€14€671€0▼ 100%
Line202320242025Change
Profit (loss) for the period9904€12,456€53,783€26,570▼ 50.6%
+ Depreciation and write-downs630€3,831€2,725€4,031▲ 47.9%
Operating cash flow (approximation)€16,287€56,508€30,601▼ 45.8%
Investment in fixed assets (approximation)-€14,246-€5,094▼ 136%
Change in cash-€82,060€3,699▼ 95.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
05-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
28-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
31-12
Financial Highest result since 2023net €53,783 ▲332%
Operating result €69,740, net result €53,783, both a record.
31-12
Financial Liquidity triplescurrent ratio 1.85
Current ratio from 0.72 to 1.85.
20-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Neupré · 1 establishment unit since 2023
seat establishment The establishment unit on the map
Ground area
1,559 m²
Building footprint
165 m²
Volume, LiDAR
1,079 m³
2 parcels, Wallonia · tallest building 8.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Place des Cèdres(N) 12, 4121 Neupré
General medical practice
since 20232.347.171.851
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
61044E0464/00S000 Wallonia 1,014 m² 1 · 95 m² 7.8 m · 2 fl.
61044E0186/00K003 Wallonia 545 m² 1 · 69 m² 8.2 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,130 companies in sector 86210 we hold annual accounts for 6,337. 5,242 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded27-06-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
E-mail dr.salvaggiojordan@gmail.com
Phone 0493864230
E-invoicing
Reachable via Peppol
Peppol ID 0208:0803242350
Registered 28-08-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.